TSMC profit soars despite 28-nm supply shortage
Peter Clarke, EETimes
7/19/2012 5:55 AM EDT
LONDON – A shortage of wafers for customers at the 28-nm process node has been no barrier to sharply increased profits at leading foundry Taiwan Semiconductor Manufacturing Co. Ltd. (Hsinchu, Taiwan). TSMC said it plans to double shipments of 28-nm in the next quarter. The company expects to expand sales revenue by about 7 percent sequentially in 3Q12.
TSMC made a net profit of NT$41.81 billion (about $1.39 billion) on sales revenue of NT$128.06 billion (about $4.27 billion) in the second quarter of 2012. The profit was up 16.3 percent on 2Q11 and the sales revenue was up 15.9 percent. Sequentially the profit jumped up by 24.9 percent while revenue was up 21.4 percent on the first quarter.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Report: UMC benefits from TSMC 28-nm supply shortage
- Qualcomm engages other foundries amid 28-nm capacity shortage
- TSMC's Chang: 'The worst is behind us' on 28-nm
- Synopsys, Altera and TSMC Collaborate to Deliver Silicon-Accurate Parasitic Modeling and Extraction for 28-nm Processes
- Synopsys Announces DesignWare Embedded Memories and Logic Libraries for TSMC 28-nanometer Processes
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design